Fig. 5
From: hsa-mir-483-3p modulates delayed breast cancer recurrence
miR483-3p interrupts the expression of OGT. (A) miR483-3p binding sites in the 3’UTR of OGT based on TargetScan prediction. Immunoblot analysis was conducted on parental MCF7 (B) and EFM19 (C) cells transfected with miRNA control or miR483-3p. Graph shows the quantification of the protein expression levels of OGT compared with GAPDH (n = 3, unpaired t-test, *p < 0.05, ****p < 0.0001).
